Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Imatinib → Imatinib Mesylate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Imatinib | HCID 5291 | — |
| 반응물 | Methanesulfonic Acid | HCID 6395 | — |
| 용매 | Ethanol | HCID 702 | — |
| 생성물 | Imatinib Mesylate | HCID 123596 | — |
반응 단계
Imatinib base (3 g) was suspended in ethanol (60 ml, 96%) at −10° C. Methanesulfonic acid (0.375 ml) was added with stirring and the suspension was stirred for additional 20 min at −5° C. obtaining thus the solution of imatinib mesylate. Than the solution was allowed to crystallize without stirring at −5° C. for 3 hours. t-Butyl methyl ether (50 ml) was added, the white solid was filtered, washed with petrolether (50 ml) and dried in a stream of nitrogen for 1 h to obtain imatinib mesylate Form IV (3.18 g, yield: 89%).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08067421B2 |
| 출처 데이터셋 | uspto-grants-2011_11 |
| ORD ID | ord-3a344cee79744152b4c2ba35e0138220 |
| 출처 메모 | uspto-grants-2011_11 |